Insight

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Photo of Ilya Tsimafeyeu

Jul 23, 2024, 10:09

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Ilya Tsimafeyeu, Director at the Bureau of Cancer Research, shared on Facebook about a recent paper titled “Intrapleural nivolumab in cancer patients with pleural effusion” published in the Journal of Cancer Research and Therapeutics.

Authors: Tsimafeyeu Ilya, Goutnik Vadim, Shrainer Igor, Kosyrev Vladislav, Bondarenko Anastasia, Utyashev Igor

Ilya Tsimafeyeu

“We tried to use intrapleural nivolumab in cancer patients with pleural effusion, but unfortunately, it did not yield the desired results.

How do you treat recurrent, resistant pleural effusions in your practice?”

Source: Ilya Tsimafeyeu/Facebook

Bondarenko Anastasia cancer Goutnik Vadim Ilya Tsimafeyeu Journal of Cancer Research and Therapeutics Kosyrev Vladislav nivolumab OncoDaily Oncology pleural effusion Shrainer Igor Tsimafeyeu Ilya Utyashev Igor

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success